European Immunology

Nanotechnology-Enabled Immune Delivery Systems

Nanotechnology is revolutionizing immunology by enabling precise delivery of antigens, drugs, nucleic acids and adjuvants directly to targeted immune cells and tissues. Nanocarriers such as liposomes, polymeric nanoparticles, dendrimers and biomimetic vesicles—enhance therapeutic stability, controlled release and biodistribution. These systems improve vaccine potency, support tumor-targeted immunotherapy and reduce systemic toxicity. Researchers are designing smart particles that respond to microenvironmental cues, ensuring localized action in sites of infection or tumors. Nanotechnology supports gene editing delivery, cytokine modulation and lymphoid organ targeting with unprecedented specificity. As safety profiles improve, nano-enabled immune therapies are expected to become central components of future biomedical interventions.